CA98420N1050 - XENE - A12ETN (XNMS)
XENON PHARMACEUTICALS INC Aktie
40,79 USD
Aktuelle Kurse von XENON PHARMACEUTICALS INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
XENE
|
USD
|
19.09.2024 22:37
|
40,79 USD
| 40,09 USD | 1,75 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -0,12 % | 6,47 % | 12,52 % | -8,03 % | 11,08 % | 341,93 % |
Firmenprofil zu XENON PHARMACEUTICALS INC Aktie
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other potential indications, including adult focal epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop PCRX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Investierte Fonds
Folgende Fonds haben in XENON PHARMACEUTICALS INC investiert:
Fonds | Vol. in Mio 25,16 | Anteil (%) 0,06 % |
Unternehmensdaten zur XENON PHARMACEUTICALS INC Aktie
Name XENON PHARMACEUTICALS INC
Firma Xenon Pharmaceuticals Inc.
Symbol XENE
Website https://www.xenon-pharma.com
Heimatbörse
NASDAQ/NMS (GLOBAL MARKET)
WKN A12ETN
ISIN CA98420N1050
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.
Marktkapitalisierung 3 Mrd.
Land Kanada
Währung USD
Mitarbeiter 0,3 T
Adresse 3650 Gilmore Way, V5G 4W8 Burnaby
IPO Datum 2014-11-05
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | XP0.F |
NASDAQ | XENE |
Weitere Aktien
Investoren die XENON PHARMACEUTICALS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024